Incruse Ellipta, Anoro Ellipta
For Spiriva Respimat®
Spiolto Respimat® is a LAMA/LABA combination therapy and comprises tiotropium (Spiriva®) and olodaterol (a LABA)
Tiotropium Respimat® 5 μg and 20 μg significantly improved lung function compared with placebo Respimat® (difference in trough FEV 1 response = 0
Safety was
People with asthma who take long-acting beta 2-agonist (LABA) medicines, such as olodaterol, (one of the medicines in STIOLTO), without also using a medicine called an inhaled corticosteroid, have an increased risk of serious problems from asthma, SPIRIVA RESPIMAT, 1
SPIRIVA RESPIMAT, 1
5 mcg or 5 mcg)
6 It is indicated for long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema, and for the Stiolto Respimat contains tiotropium, a long-acting anticholinergic, and olodaterol, a long-acting beta2-agonist (LABA)
25 mcg, is a bronchodilator indicated for the long-term, once-daily, maintenance treatment of asthma in patients 6 years of age and older
STIOLTO® RESPIMAT® (tiotropium bromide and olodaterol) Inhalation Spray is a combination of tiotropium, an anticholinergic, and olodaterol, a long-acting beta 2-adrenergic agonist (LABA), indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or
rash, itching or hives on the skin
It is inhaled in 2 puffs, 1 time each day
Tiotropium (Spiriva Handihaler, Spiriva Respimat) Umeclidinium (Incruse Ellipta) Aclidinium (Tudorza Pressair) Glycopyrrolate (Lonhala Magnair) Revefenacin (Yupelri) Precautions